Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.
Also called NCT02434744
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 121 participants
- Sponsor
- Response Pharmaceuticals
- Registry
-
NCT02434744
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02434744. Randomized; quadruple masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2016-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- KD026
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Metformin
- Lead sponsor
- Response Pharmaceuticals
Record details
- Record id
cardio:ct-nct02434744- Content hash
c8f4f9db587080715683e6c74a19e4c028290b85ff1c78646a38f7a9b84ad5f6